Deutsche Bank’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-574
Closed -$5.99K 4067
2023
Q1
$5.99K Hold
574
﹤0.01% 3825
2022
Q4
$5.87K Buy
+574
New +$5.81K ﹤0.01% 3886

Deutsche Bank's LVAC Position: Q2 2023 in Review

Deutsche Bank sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 574 shares — an estimated $5.99K sold.

Deutsche Bank first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $5.99K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

  • Deutsche Bank reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 574 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $5.99K.
  • Deutsche Bank first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • Deutsche Bank's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $5.99K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.